Parkinson's develops when nerve cells in a specific brain region stop producing enough dopamine
Parkinson's disease happens when neurons (nerve cells) in a part of your brain called the substantia nigra begin to die or malfunction. These cells normally produce a chemical messenger called dopamine, which helps control movement, balance, and coordination. When dopamine levels drop—usually by 60 percent or more—the movement problems that define Parkinson's start to appear. The disease is not contagious and is not directly inherited in most cases, though genetics do play a role in who develops it.
Scientists do not yet know exactly why these dopamine-producing cells die in some people and not others. The process typically unfolds over years or decades before symptoms become noticeable. By the time someone receives a diagnosis, significant cell loss has already occurred. This is why Parkinson's is sometimes called a neurodegenerative disease—the nerve cells gradually degenerate over time.
Key Takeaways
- Parkinson's occurs when dopamine-producing nerve cells in the brain deteriorate, reducing the chemical that controls movement.
- The exact cause remains unknown, but both genetic and environmental factors appear to increase risk in different people.
- Most people with Parkinson's do not have a family history of the disease, meaning genetics alone does not determine who gets it.
- Symptoms typically appear only after substantial nerve cell loss has already happened, which is why early detection is difficult.
- Age is the strongest known risk factor—Parkinson's is rare before age 50 and becomes more common as people get older.
The role of genetics in Parkinson's risk
If a parent or sibling has Parkinson's, your risk is higher than the general population, but it is still relatively low. Researchers have identified several genes that, when mutated, increase the chance of developing the disease. The most well-studied are SNCA, LRRK2, and GBA. However, carrying one of these genetic variants does not mean you will definitely develop Parkinson's—many people with the mutation never do.
Genetic forms of Parkinson's account for roughly 10 to 15 percent of all cases. The remaining 85 to 90 percent appear to result from a combination of age, environmental exposures, and possibly random cellular events. This is why two siblings with the same genetic risk may have very different outcomes: one develops the disease and the other does not.
Environmental and lifestyle factors that may increase risk
Certain exposures in your environment or work history may raise the likelihood of developing Parkinson's, though none of them may provide it will happen. Pesticide exposure—particularly in agricultural settings—has been linked to higher rates of the disease in some studies. Head injuries, especially repeated ones, have also been associated with increased risk later in life. Some research suggests that living in rural areas or drinking well water may carry slightly higher risk, possibly due to pesticide or mineral exposure.
Other factors under investigation include viral infections, certain medications, and occupational exposures to metals or solvents. The relationship between these factors and Parkinson's is not fully understood, and most people exposed to these things do not develop the disease. Age remains the strongest predictor: Parkinson's is uncommon before age 50 but becomes increasingly common in people over 60.
What happens inside the brain during Parkinson's
The death of dopamine-producing cells is often accompanied by the buildup of a protein called alpha-synuclein. In healthy brains, this protein is broken down and recycled normally. In Parkinson's, it accumulates into clumps called Lewy bodies, which appear to damage and kill nerve cells. Researchers believe this protein buildup may be central to the disease process, though they are still working to understand exactly how it causes cell death.
The loss of dopamine affects not only movement but also mood, sleep, and thinking. As the disease progresses, it can damage other brain regions and affect other neurotransmitters—chemical messengers beyond dopamine. This is why Parkinson's symptoms extend beyond tremor and stiffness to include depression, sleep problems, and cognitive changes in some people.
Why Parkinson's is difficult to predict or prevent
Because the underlying cause remains unknown, there is currently no proven way to prevent Parkinson's from developing. Some research suggests that regular physical activity, cognitive engagement, and a Mediterranean-style diet may be associated with lower risk, but these have not been proven to prevent the disease. Similarly, avoiding known risk factors—such as pesticide exposure—may reduce risk, but cannot eliminate it entirely.
The disease typically develops silently over many years before movement symptoms appear. By the time someone notices tremor or stiffness, the dopamine-producing cells have already undergone substantial loss. This long asymptomatic period makes early detection extremely challenging, even with modern imaging technology. Researchers are working on biomarkers—measurable signs in blood or cerebrospinal fluid—that might identify people at risk before symptoms start, but these tools are not yet available for routine screening.
The difference between Parkinson's and Parkinsonism
It is important to distinguish between Parkinson's disease itself and a broader category called Parkinsonism. Parkinsonism refers to any condition that causes Parkinson's-like symptoms—tremor, rigidity, and slow movement. These symptoms can result from other causes, including certain medications (particularly antipsychotics), other neurological diseases, head injuries, or toxin exposure.
True Parkinson's disease is diagnosed when a person has the characteristic movement symptoms and responds well to dopamine-replacement medications. Other forms of Parkinsonism may not respond to these medications and may have different underlying causes. A neurologist can usually distinguish between them through examination and sometimes imaging studies.
What researchers are still trying to understand
Scientists continue to investigate why dopamine-producing cells die in Parkinson's and what triggers the process. Current research focuses on inflammation in the brain, mitochondrial dysfunction (problems with the cell's energy-producing structures), and the role of the immune system. Some studies are examining whether Parkinson's might begin in the gut and spread to the brain, based on observations that gut problems often precede movement symptoms.
Understanding the root cause could eventually lead to treatments that slow or stop the disease before symptoms appear. For now, available treatments address symptoms by boosting dopamine levels or mimicking its effects, but they do not halt the underlying nerve cell loss. This is why ongoing research into prevention and early detection remains a major focus in Parkinson's science.
Frequently Asked Questions
Can you catch Parkinson's from someone else?
No. Parkinson's is not contagious and cannot be transmitted from one person to another. It develops due to changes in a person's own brain cells and is influenced by their genetics and environment.
If my parent has Parkinson's, will I definitely get it?
No. Having a parent with Parkinson's increases your risk compared to the general population, but most people with a family history never develop the disease. Genetics is one factor among many, and it does not determine your outcome with certainty.
Does stress cause Parkinson's?
Stress does not cause Parkinson's, though it may worsen symptoms in people who already have the disease. The underlying cause involves changes in brain cells that develop over years, independent of stress levels.
Can lifestyle changes prevent Parkinson's?
While regular exercise, mental stimulation, and a healthy diet may be associated with lower risk in some research, no lifestyle change has been proven to prevent Parkinson's. These habits are beneficial for overall health regardless.
Why do symptoms appear suddenly if the disease develops slowly?
Symptoms become noticeable only after substantial dopamine loss has occurred—usually 60 percent or more. The underlying cell death happens gradually over years, but once it reaches a critical threshold, movement problems emerge relatively quickly.